Verition Fund Management LLC Novartis Ag Transaction History

Verition Fund Management LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Nov 16, 2020	SELL	$82.14 - $91.0 $219,806 - $243,516	-2,676 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$80.93 - $91.1 $216,568 - $243,783	2,676 New	2,676 $234,000
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $228,220 - $251,485	-2,668 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$75.4 - $92.8 $201,167 - $247,590	2,668 New	2,668 $244,000
Q1 2019 May 15, 2019	SELL	$75.32 - $86.15 $677,804 - $775,263	-8,999 Closed	0 $0
Q4 2018 Feb 14, 2019	BUY	$73.66 - $82.02 $662,866 - $738,097	8,999 New	8,999 $772,000
Q3 2018 Nov 15, 2018	SELL	$66.94 - $77.43 $2.62 Million - $3.03 Million	-39,193 Closed	0 $0
Q2 2018 Aug 15, 2018	BUY	$64.91 - $73.36 $1.86 Million - $2.1 Million	28,679 Added 272.77%	39,193 $2.96 Million
Q1 2018 May 16, 2018	BUY	$70.39 - $84.15 $460,913 - $551,014	6,548 Added 165.1%	10,514 $850,000
Q4 2017 Feb 15, 2018	BUY	$72.33 - $77.64 $286,860 - $307,920	3,966	3,966 $333,000

1,435

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $224B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

Stay updated on Verition Fund Management LLC with notifications on news.